InvestorsHub Logo
Followers 0
Posts 17
Boards Moderated 0
Alias Born 03/18/2014

Re: andyshow post# 6460

Wednesday, 03/26/2014 3:56:58 AM

Wednesday, March 26, 2014 3:56:58 AM

Post# of 106840
What are your thoughts on the MARVEL and REGEN trials for MyoCell? According to the 10K they seem unfunded since 2010, yet MARVEL shows up as ongoing on the clinical trials web site, but not recruiting. The 10-K has the MARVEL at full stop due to funding, hence the reason why it's not recruiting? Would be a big difference versus full participation.

Also, is the MIRROR trial a third avenue to the approval of MyoCell? Whichever gets here first type scenario? Or is it for a specific application, of the MyoCell product intended for each?

One line in the 10K for MIRROR and no other, non-PR, public information.

On that note, I still have not heard back from clinicaltrials.gov regarding the MIRROR, as such a reason why I would like to see it published to have more public information as to the trial objectives and progress.

Final thought, if these are so far along, why start trials in other unrelated areas? Is it because they're in Phase I and easier to complete? Cost wise, resource wise?

Or is it that the company has encountered a more significant barrier pursuing their original objective in MARVEL, REGEN, and MIRROR trials?

I understand the financial nature of this early phase development biotech, so we're investing in the future knowing knowing cash flow is through equity and debt funding against an "estimated" time line.

The key for me is how they're spending that money and time to progress their flagship offerings. These are some of the questions I'm currently thinking about as I try to navigate through all the distractions and come to a better informed decision point. Any thoughts?